Skip to main content
NCBI home page
Gut logoLink to Gut
. 2000 Apr;46(4):443–446. doi: 10.1136/gut.46.4.443

Is liver fibrosis reversible?

R BENYON 1, J IREDALE 1
PMCID: PMC1727904  PMID: 10716665

Full Text

The Full Text of this article is available as a PDF (85.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Aziz G., Lebeau G., Rescan P. Y., Clément B., Rissel M., Deugnier Y., Campion J. P., Guillouzo A. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am J Pathol. 1990 Dec;137(6):1333–1342. [PMC free article] [PubMed] [Google Scholar]
  2. Aimes R. T., Quigley J. P. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem. 1995 Mar 17;270(11):5872–5876. doi: 10.1074/jbc.270.11.5872. [DOI] [PubMed] [Google Scholar]
  3. Arthur M. J. Matrix degradation in liver: a role in injury and repair. Hepatology. 1997 Oct;26(4):1069–1071. doi: 10.1002/hep.510260440. [DOI] [PubMed] [Google Scholar]
  4. Baker A. J., Mooney A., Hughes J., Lombardi D., Johnson R. J., Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest. 1994 Nov;94(5):2105–2116. doi: 10.1172/JCI117565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Benyon R. C., Arthur M. J. Mechanisms of hepatic fibrosis. J Pediatr Gastroenterol Nutr. 1998 Jul;27(1):75–85. doi: 10.1097/00005176-199807000-00013. [DOI] [PubMed] [Google Scholar]
  6. Benyon R. C., Iredale J. P., Goddard S., Winwood P. J., Arthur M. J. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology. 1996 Mar;110(3):821–831. doi: 10.1053/gast.1996.v110.pm8608892. [DOI] [PubMed] [Google Scholar]
  7. Bissell D. M., Arenson D. M., Maher J. J., Roll F. J. Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest. 1987 Mar;79(3):801–812. doi: 10.1172/JCI112887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bissell D. M., Caron J. M., Babiss L. E., Friedman J. M. Transcriptional regulation of the albumin gene in cultured rat hepatocytes. Role of basement-membrane matrix. Mol Biol Med. 1990 Apr;7(2):187–197. [PubMed] [Google Scholar]
  9. Burt A. D. C. L. Oakley Lecture (1993). Cellular and molecular aspects of hepatic fibrosis. J Pathol. 1993 Jun;170(2):105–114. doi: 10.1002/path.1711700203. [DOI] [PubMed] [Google Scholar]
  10. Burt A. D., Griffiths M. R., Schuppan D., Voss B., MacSween R. N. Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling. Histopathology. 1990 Jan;16(1):53–58. doi: 10.1111/j.1365-2559.1990.tb01060.x. [DOI] [PubMed] [Google Scholar]
  11. Carmeliet P., Collen D. Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res. 1998 Sep 15;91(6):255–285. doi: 10.1016/s0049-3848(98)00122-4. [DOI] [PubMed] [Google Scholar]
  12. Carter E. A., McCarron M. J., Alpert E., Isselbacher K. J. Lysyl oxidase and collagenase in experimental acute and chronic liver injury. Gastroenterology. 1982 Mar;82(3):526–534. [PubMed] [Google Scholar]
  13. Darby I., Skalli O., Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest. 1990 Jul;63(1):21–29. [PubMed] [Google Scholar]
  14. Desmoulière A., Redard M., Darby I., Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol. 1995 Jan;146(1):56–66. [PMC free article] [PubMed] [Google Scholar]
  15. Dufour J. F., DeLellis R., Kaplan M. M. Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment. Dig Dis Sci. 1998 Dec;43(12):2573–2576. doi: 10.1023/a:1026601904609. [DOI] [PubMed] [Google Scholar]
  16. Dufour J. F., DeLellis R., Kaplan M. M. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med. 1997 Dec 1;127(11):981–985. doi: 10.7326/0003-4819-127-11-199712010-00006. [DOI] [PubMed] [Google Scholar]
  17. Friedman S. L., Roll F. J., Boyles J., Arenson D. M., Bissell D. M. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem. 1989 Jun 25;264(18):10756–10762. [PubMed] [Google Scholar]
  18. Frisch S. M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994 Feb;124(4):619–626. doi: 10.1083/jcb.124.4.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gong W., Pecci A., Roth S., Lahme B., Beato M., Gressner A. M. Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology. 1998 Aug;28(2):492–502. doi: 10.1002/hep.510280229. [DOI] [PubMed] [Google Scholar]
  20. Gressner A. M., Haarmann R. Hyaluronic acid synthesis and secretion by rat liver fat storing cells (perisinusoidal lipocytes) in culture. Biochem Biophys Res Commun. 1988 Feb 29;151(1):222–229. doi: 10.1016/0006-291x(88)90582-7. [DOI] [PubMed] [Google Scholar]
  21. Hahn E., Wick G., Pencev D., Timpl R. Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin. Gut. 1980 Jan;21(1):63–71. doi: 10.1136/gut.21.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Herbst H., Wege T., Milani S., Pellegrini G., Orzechowski H. D., Bechstein W. O., Neuhaus P., Gressner A. M., Schuppan D. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol. 1997 May;150(5):1647–1659. [PMC free article] [PubMed] [Google Scholar]
  23. Iredale J. P., Benyon R. C., Arthur M. J., Ferris W. F., Alcolado R., Winwood P. J., Clark N., Murphy G. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 1996 Jul;24(1):176–184. doi: 10.1002/hep.510240129. [DOI] [PubMed] [Google Scholar]
  24. Iredale J. P., Benyon R. C., Pickering J., McCullen M., Northrop M., Pawley S., Hovell C., Arthur M. J. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998 Aug 1;102(3):538–549. doi: 10.1172/JCI1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Iredale J. P., Goddard S., Murphy G., Benyon R. C., Arthur M. J. Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci (Lond) 1995 Jul;89(1):75–81. doi: 10.1042/cs0890075. [DOI] [PubMed] [Google Scholar]
  26. Iredale J. P., Murphy G., Hembry R. M., Friedman S. L., Arthur M. J. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest. 1992 Jul;90(1):282–287. doi: 10.1172/JCI115850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Iwamoto H., Sakai H., Tada S., Nakamuta M., Nawata H. Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion. J Lab Clin Med. 1999 Jul;134(1):83–89. doi: 10.1016/s0022-2143(99)90057-4. [DOI] [PubMed] [Google Scholar]
  28. Jarnagin W. R., Rockey D. C., Koteliansky V. E., Wang S. S., Bissell D. M. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol. 1994 Dec;127(6 Pt 2):2037–2048. doi: 10.1083/jcb.127.6.2037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Knittel T., Fellmer P., Ramadori G. Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver. Gastroenterology. 1996 Sep;111(3):745–754. doi: 10.1053/gast.1996.v111.pm8780581. [DOI] [PubMed] [Google Scholar]
  30. Knittel T., Mehde M., Kobold D., Saile B., Dinter C., Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol. 1999 Jan;30(1):48–60. doi: 10.1016/s0168-8278(99)80007-5. [DOI] [PubMed] [Google Scholar]
  31. Kossakowska A. E., Edwards D. R., Lee S. S., Urbanski L. S., Stabbler A. L., Zhang C. L., Phillips B. W., Zhang Y., Urbanski S. J. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol. 1998 Dec;153(6):1895–1902. doi: 10.1016/S0002-9440(10)65703-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Leyland H., Gentry J., Arthur M. J., Benyon R. C. The plasminogen-activating system in hepatic stellate cells. Hepatology. 1996 Nov;24(5):1172–1178. doi: 10.1002/hep.510240532. [DOI] [PubMed] [Google Scholar]
  33. Lichtinghagen R., Breitenstein K., Arndt B., Kühbacher T., Böker K. H. Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver. Virchows Arch. 1998 Feb;432(2):153–158. doi: 10.1007/s004280050149. [DOI] [PubMed] [Google Scholar]
  34. Maruyama K., Feinman L., Fainsilber Z., Nakano M., Okazaki I., Lieber C. S. Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci. 1982 Apr 19;30(16):1379–1384. doi: 10.1016/0024-3205(82)90023-6. [DOI] [PubMed] [Google Scholar]
  35. Matrisian L. M. The matrix-degrading metalloproteinases. Bioessays. 1992 Jul;14(7):455–463. doi: 10.1002/bies.950140705. [DOI] [PubMed] [Google Scholar]
  36. McGuire R. F., Bissell D. M., Boyles J., Roll F. J. Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver. Hepatology. 1992 Jun;15(6):989–997. doi: 10.1002/hep.1840150603. [DOI] [PubMed] [Google Scholar]
  37. Milani S., Herbst H., Schuppan D., Grappone C., Pellegrini G., Pinzani M., Casini A., Calabró A., Ciancio G., Stefanini F. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol. 1994 Mar;144(3):528–537. [PMC free article] [PubMed] [Google Scholar]
  38. Mirza A., Liu S. L., Frizell E., Zhu J., Maddukuri S., Martinez J., Davies P., Schwarting R., Norton P., Zern M. A. A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol. 1997 Feb;272(2 Pt 1):G281–G288. doi: 10.1152/ajpgi.1997.272.2.G281. [DOI] [PubMed] [Google Scholar]
  39. Montfort I., Pérez-Tamayo R. Collagenase in experimental carbon tetrachloride cirrhosis of the liver. Am J Pathol. 1978 Aug;92(2):411–420. [PMC free article] [PubMed] [Google Scholar]
  40. Murphy G., Stanton H., Cowell S., Butler G., Knäuper V., Atkinson S., Gavrilovic J. Mechanisms for pro matrix metalloproteinase activation. APMIS. 1999 Jan;107(1):38–44. doi: 10.1111/j.1699-0463.1999.tb01524.x. [DOI] [PubMed] [Google Scholar]
  41. Niederau C., Fischer R., Sonnenberg A., Stremmel W., Trampisch H. J., Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985 Nov 14;313(20):1256–1262. doi: 10.1056/NEJM198511143132004. [DOI] [PubMed] [Google Scholar]
  42. Nilsson G., Forsberg-Nilsson K., Xiang Z., Hallbök F., Nilsson K., Metcalfe D. D. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol. 1997 Sep;27(9):2295–2301. doi: 10.1002/eji.1830270925. [DOI] [PubMed] [Google Scholar]
  43. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem. 1997 Jan 24;272(4):2446–2451. doi: 10.1074/jbc.272.4.2446. [DOI] [PubMed] [Google Scholar]
  44. Okazaki I., Maruyama K. Collagenase activity in experimental hepatic fibrosis. Nature. 1974 Nov 1;252(5478):49–50. doi: 10.1038/252049a0. [DOI] [PubMed] [Google Scholar]
  45. Perez-Tamayo R., Montfort I., Gonzalez E. Collagenolytic activity in experimental cirrhosis of the liver. Exp Mol Pathol. 1987 Dec;47(3):300–308. doi: 10.1016/0014-4800(87)90015-3. [DOI] [PubMed] [Google Scholar]
  46. Piacentini M., Autuori F., Dini L., Farrace M. G., Ghibelli L., Piredda L., Fesus L. "Tissue" transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor-stimulation. Cell Tissue Res. 1991 Feb;263(2):227–235. doi: 10.1007/BF00318764. [DOI] [PubMed] [Google Scholar]
  47. Ricard-Blum S., Bresson-Hadni S., Guerret S., Grenard P., Volle P. J., Risteli L., Grimaud J. A., Vuitton D. A. Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology. 1996 Jul;111(1):172–182. doi: 10.1053/gast.1996.v111.pm8698196. [DOI] [PubMed] [Google Scholar]
  48. Rojkind M., Giambrone M. A., Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology. 1979 Apr;76(4):710–719. [PubMed] [Google Scholar]
  49. Saile B., Knittel T., Matthes N., Schott P., Ramadori G. CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. Am J Pathol. 1997 Nov;151(5):1265–1272. [PMC free article] [PubMed] [Google Scholar]
  50. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis. 1990 Feb;10(1):1–10. doi: 10.1055/s-2008-1040452. [DOI] [PubMed] [Google Scholar]
  51. Seyer J. M., Hutcheson E. T., Kang A. H. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest. 1977 Feb;59(2):241–248. doi: 10.1172/JCI108634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sobesky R., Mathurin P., Charlotte F., Moussalli J., Olivi M., Vidaud M., Ratziu V., Opolon P., Poynard T. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. Gastroenterology. 1999 Feb;116(2):378–386. doi: 10.1016/s0016-5085(99)70135-6. [DOI] [PubMed] [Google Scholar]
  53. Takahashi S., Dunn M. A., Seifter S. Liver collagenase in murine schistosomiasis. Gastroenterology. 1980 Jun;78(6):1425–1431. [PubMed] [Google Scholar]
  54. Vater C. A., Harris E. D., Jr, Siegel R. C. Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem J. 1979 Sep 1;181(3):639–645. doi: 10.1042/bj1810639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Zhang K., Rekhter M. D., Gordon D., Phan S. H. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol. 1994 Jul;145(1):114–125. [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES